← Leaderboards

Joseph D. Buxbaum

Mount Sinai School Of Medicine Of Cuny

Google Scholar ↗PubMed ↗ORCID ↗

$36,303,109

Attributed

$41,399,458

Total exposure

29

Grants

23

Lead (contact PI)

Attributed= this PI's even-split share of every grant they're on (the fair, additive number). Exposure = full size of all those grants.

Funding over time

peak $5M · FY2005–25

$5M$3.8M$2.5M$1.3M$0

'05

'06

'07

'08

'09

'10

'11

'12

'13

'14

'15

'16

'17

'18

'19

'20

'21

'22

'23

'24

'25

Funding mix

By agency

NIH$52,802,826 · 31

By mechanism

R01$23,477,708 · 10

P50$14,318,618 · 5

U01$6,816,402 · 3

P01$3,311,499 · 4

U54$2,487,840 · 3

R56$1,324,466 · 1

Top collaborators

Others in their field

Top investigators on “Genes”

David Heimbrook · Leidos Biomedical Research, Inc.$413,811,031
Richard A Gibbs · Baylor College Of Medicine$338,750,128
Barton F Haynes · Duke University$304,076,400
Stacey Gabriel · Massachusetts Institute Of Technology$241,252,013
Eric S Lander · Whitehead Institute For Biomedical Res$211,825,987
Richard K. Wilson · Washington University$195,881,965

Research focus

GenesBaseAffectGeneticSamplingVariantLeadAutism Spectrum DisorderInnovationSchizophreniaPhenotypeMolecularUnited States National Institutes Of HealthPathway InteractionsBrainMissionComplexResearch PersonnelSymptomsGenetic RiskDiagnosisInsightSiteProteins

Grant awards (124)

Genomics of Autism in Latinx Ancestries$608,945

R01 · FY2025 · MH · contact PI

1/4 - The Autism Sequencing Consortium: Discovering autism risk genes and how they impact core features of the disorder$353,002

R01 · FY2025 · MH · contact PI

Pilot project$36,148

U54 · FY2025 · NS · contact PI

Genomics of Autism in Latinx Ancestries$752,063

R01 · FY2024 · MH · contact PI

1/4 - The Autism Sequencing Consortium: Discovering autism risk genes and how they impact core features of the disorder$415,296

R01 · FY2024 · MH · contact PI

Genomics of Autism in Latinx Ancestries$782,014

R01 · FY2023 · MH · contact PI

Pooled Optical Imaging, Neurite Tracing, and Morphometry Across Perturbations (POINT-MAP).$464,750

R21 · FY2023 · MH · contact PI

1/4 - The Autism Sequencing Consortium: Discovering autism risk genes and how they impact core features of the disorder$415,296

R01 · FY2023 · MH · contact PI

Genomics of Autism in Latinx Ancestries$771,560

R01 · FY2022 · MH · contact PI

1/4 - The Autism Sequencing Consortium: Discovering autism risk genes and how they impact core features of the disorder$449,796

R01 · FY2022 · MH · contact PI

Population-Based Autism Genetics and Environment Study$445,405

R01 · FY2022 · MH · contact PI

1/4 - The Autism Sequencing Consortium: Autism Gene Discovery in >50,000 Exomes$508,546

U01 · FY2021 · MH · contact PI

Large-scale reprogramming and expression analysis of patient-derived neural cells in schizophrenia$498,247

R01 · FY2021 · MH · contact PI

Population-Based Autism Genetics and Environment Study$469,559

R01 · FY2021 · MH · contact PI

Large-scale reprogramming and expression analysis of patient-derived neural cells in schizophrenia$804,759

R01 · FY2020 · MH · contact PI

Population-Based Autism Genetics and Environment Study$648,139

R01 · FY2020 · MH · contact PI

1/4 - The Autism Sequencing Consortium: Autism Gene Discovery in >50,000 Exomes$508,546

U01 · FY2020 · MH · contact PI

Large-scale reprogramming and expression analysis of patient-derived neural cells in schizophrenia$801,762

R01 · FY2019 · MH · contact PI

Population-Based Autism Genetics and Environment Study$646,960

R01 · FY2019 · MH · contact PI

1/4 - The Autism Sequencing Consortium: Autism Gene Discovery in >50,000 Exomes$508,546

U01 · FY2019 · MH · contact PI

Large-scale reprogramming and expression analysis of patient-derived neural cells in schizophrenia$289,041

R01 · FY2019 · MH · contact PI

Population-Based Autism Genetics and Environment Study$159,808

R01 · FY2019 · MH · contact PI

Large-scale reprogramming and expression analysis of patient-derived neural cells in schizophrenia$799,467

R01 · FY2018 · MH · contact PI

Population-Based Autism Genetics and Environment Study$732,418

R01 · FY2018 · MH · contact PI

1/4 - The Autism Sequencing Consortium: Autism Gene Discovery in >50,000 Exomes$508,546

U01 · FY2018 · MH · contact PI

Prefrontal function in the Shank3-deficient rat: A first rat model for ASD$457,912

R01 · FY2018 · MH · contact PI

Large-scale reprogramming and expression analysis of patient-derived neural cells in schizophrenia$853,822

R01 · FY2017 · MH · contact PI

1/4 - The Autism Sequencing Consortium: Autism Gene Discovery in >50,000 Exomes$543,296

U01 · FY2017 · MH · contact PI

Prefrontal function in the Shank3-deficient rat: A first rat model for ASD$457,912

R01 · FY2017 · MH · contact PI

Development of Behavioral and Neural Biomarkers for Autism Spectrum Disorder Using a Genetically Defined Subtype$211,875

R21 · FY2017 · MH · contact PI

Population-Based Autism Genetics & Environment Study$640,712

R01 · FY2016 · MH · contact PI

Prefrontal function in the Shank3-deficient rat: A first rat model for ASD$457,912

R01 · FY2016 · MH · contact PI

Development of Behavioral and Neural Biomarkers for Autism Spectrum Disorder Using a Genetically Defined Subtype$232,184

R21 · FY2016 · MH · contact PI

1/4-The Autism Sequencing Consortium: Autism gene discovery in >20,000 exomes$720,372

U01 · FY2015 · MH · contact PI

Population-Based Autism Genetics & Environment Study$618,149

R01 · FY2015 · MH · contact PI

Identifying therapeutic targets for autism using Shank3-deficient mice$487,448

R01 · FY2015 · MH · contact PI

Prefrontal function in the Shank3-deficient rat: A first rat model for ASD$457,912

R01 · FY2015 · MH · contact PI

1/4-The Autism Sequencing Consortium: Autism gene discovery in >20,000 exomes$206,585

U01 · FY2015 · MH · contact PI

Population-Based Autism Genetics & Environment Study$165,663

R01 · FY2015 · MH · contact PI

Targeting System Xc- for the treatment of the Autism Spectrum Disorder subpopulations, Fragile X syndrome and Phelan-McDermid syndrome$151,366

R43 · FY2015 · HD

1/4-The Autism Sequencing Consortium: Autism gene discovery in >20,000 exomes$720,372

U01 · FY2014 · MH · contact PI

Population-Based Autism Genetics & Environment Study$655,813

R01 · FY2014 · MH · contact PI

Prefrontal function in the Shank3-deficient rat: A first rat model for ASD$544,401

R01 · FY2014 · MH · contact PI

Identifying therapeutic targets for autism using Shank3-deficient mice$486,501

R01 · FY2014 · MH · contact PI

Accelerating Medicine Partnership in Alzheimer's Disease: Enabling collaborative$114,059

U01 · FY2014 · AG

Integrative Biology Approach to Complexity of Alzheimer's Disease$1,659,748

U01 · FY2013 · AG

1/4-The Autism Sequencing Consortium: Autism gene discovery in >20,000 exomes$817,786

U01 · FY2013 · MH · contact PI

Population-Based Autism Genetics & Environment Study$600,532

R56 · FY2013 · MH · contact PI

Identifying therapeutic targets for autism using Shank3-deficient mice$466,151

R01 · FY2013 · MH · contact PI

Population-Based Autism Genetics & Environment Study$723,934

R56 · FY2012 · MH · contact PI

White Matter Abnormalities in Schizophrenia$595,365

P50 · FY2012 · MH · contact PI

Identifying therapeutic targets for autism using Shank3-deficient mice$484,667

R01 · FY2012 · MH · contact PI

Identifying therapeutic targets for autism using Shank3-deficient mice$121,077

R01 · FY2012 · MH · contact PI

P4-Structure and function of white mater in schizophrenia$74,421

P50 · FY2012 · MH · contact PI

P3- PTPRZ1 signaling in schizophrenia$74,421

P50 · FY2012 · MH · contact PI

AMINISTRATIVE CORE$74,420

P50 · FY2012 · MH · contact PI

White Matter Abnormalities in Schizophrenia$1,891,932

P50 · FY2011 · MH · contact PI

Identifying therapeutic targets for autism using Shank3-deficient mice$483,773

R01 · FY2011 · MH · contact PI

P4-Structure and function of white mater in schizophrenia$300,643

P50 · FY2011 · MH · contact PI

AMINISTRATIVE CORE$192,222

P50 · FY2011 · MH · contact PI

P3- PTPRZ1 signaling in schizophrenia$185,162

P50 · FY2011 · MH · contact PI

White Matter Abnormalities in Schizophrenia$1,911,045

P50 · FY2010 · MH · contact PI

3/5-Elucidating the Genetic Architecture of Autism by Deep Genomic Sequencing$840,464

R01 · FY2010 · MH · contact PI

AMINISTRATIVE CORE$194,164

P50 · FY2010 · MH · contact PI

P3- PTPRZ1 signaling in schizophrenia$187,033

P50 · FY2010 · MH · contact PI

White Matter Abnormalities in Schizophrenia$1,933,720

P50 · FY2009 · MH · contact PI

3/5-Elucidating the Genetic Architecture of Autism by Deep Genomic Sequencing$571,568

R01 · FY2009 · MH · contact PI

ROLE OF LRP IN CELLULAR SIGNALING AND APP PROCESSING$279,283

P01 · FY2009 · AG · contact PI

IDENTIFICATION AND CHARACTERIZATION OF FIRST MESSENGERS THAT REGULATE APP$243,012

P50 · FY2009 · AG · contact PI

AMINISTRATIVE CORE$196,723

P50 · FY2009 · MH · contact PI

P3- PTPRZ1 signaling in schizophrenia$188,962

P50 · FY2009 · MH · contact PI

AUTISM GENOME PROJECT$4,894

M01 · FY2009 · RR · contact PI

GREATER NEW YORK AUTISM CENTER OF EXCELLENCE - CLINICAL CORE$1,224

M01 · FY2009 · RR · contact PI

White Matter Abnormalities in Schizophrenia$1,927,422

P50 · FY2008 · MH · contact PI

Hypercholesterolemia and Alzheimer's Disease Neurobiology$314,368

P01 · FY2008 · AG · contact PI

ROLE OF LRP IN CELLULAR SIGNALING AND APP PROCESSING$307,001

P01 · FY2008 · AG · contact PI

IDENTIFICATION AND CHARACTERIZATION OF FIRST MESSENGERS THAT REGULATE APP$237,088

P50 · FY2008 · AG · contact PI

AMINSTRATIVE CORE$196,334

P50 · FY2008 · MH · contact PI

P3- PTPRZ1 signaling in schizophrenia$188,062

P50 · FY2008 · MH · contact PI

White Matter Abnormalities in Schizophrenia$2,000,000

P50 · FY2007 · MH · contact PI

Greater New York Autism Research Center of Excellence$1,143,884

U54 · FY2007 · MH · contact PI

FUNCTION OF THE FE65/APP COMPLEX$321,433

R01 · FY2007 · AG · contact PI

Hypercholesterolemia and Alzheimer's Disease Neurobiology$317,365

P01 · FY2007 · AG · contact PI

ROLE OF LRP IN CELLULAR SIGNALING AND APP PROCESSING$310,904

P01 · FY2007 · AG · contact PI

IDENTIFICATION AND CHARACTERIZATION OF FIRST MESSENGERS THAT REGULATE APP$236,054

P50 · FY2007 · AG · contact PI

IDENTIFICATION OF AUTISM SUSCEPTIBILITY GENES$226,708

U54 · FY2007 · MH · contact PI

Core A-Administrative$202,803

P50 · FY2007 · MH · contact PI

P3- PTPRZ1 signaling in schizophrenia$192,769

P50 · FY2007 · MH · contact PI

FUNCTION OF THE FE65/APP COMPLEX$331,034

R01 · FY2006 · AG · contact PI

HYPERCHOLESTEROLEMIA AND AD NEUROBIOLOGY$280,238

P01 · FY2006 · AG · contact PI

IDENTIFICATION OF AUTISM SUSCEPTIBILITY GENES$269,900

U54 · FY2006 · MH · contact PI

ROLE OF LRP IN CELLULAR SIGNALING AND APP PROCESSING$222,223

P01 · FY2006 · AG · contact PI

IDENTIFICATION AND CHARACTERIZATION OF FIRST MESSENGERS THAT REGULATE APP$128,750

P50 · FY2006 · AG · contact PI

FUNCTION OF THE FE65/APP COMPLEX$339,000

R01 · FY2005 · AG

HYPERCHOLESTEROLEMIA AND AD NEUROBIOLOGY$277,241

P01 · FY2005 · AG

IDENTIFICATION OF AUTISM SUSCEPTIBILITY GENES$269,900

U54 · FY2005 · MH

IDENTIFICATION AND CHARACTERIZATION OF FIRST MESSENGERS THAT REGULATE APP$125,000

P50 · FY2005 · AG

ROLE OF LRP IN CELLULAR SIGNALING AND APP PROCESSING$124,128

P01 · FY2005 · AG

FUNCTION OF THE FE65/APP COMPLEX$339,000

R01 · FY2004 · AG

HYPERCHOLESTEROLEMIA AND AD NEUROBIOLOGY$274,332

P01 · FY2004 · AG

IDENTIFICATION OF AUTISM SUSCEPTIBILITY GENES$269,900

U54 · FY2004 · MH

FUNCTION OF THE FE65/APP COMPLEX$339,000

R01 · FY2003 · AG

IDENTIFICATION OF AUTISM SUSCEPTIBILITY GENES$271,400

U54 · FY2003 · MH

PRESENILINS, APOPTOSIS AND AMYLOID BETA PROTEIN$239,341

R01 · FY2003 · AG

RAB5 AND APP PROCESSING AS RELATED TO AGING$267,893

R01 · FY2002 · AG

PRESENILINS, APOPTOSIS AND AMYLOID BETA PROTEIN$232,368

R01 · FY2002 · AG

NOVEL PRESENILIN BINDING PROTEINS$196,218

P50 · FY2002 · AG

AMYLOID AND NEURITIC CHANGES IN EARLY ALZHEIMERS DISEASE$0

P01 · FY2002 · AG

Myelin Gene Products in Post Mortem Tissue$0

P50 · FY2002 · MH

Core--Amyloid Beta$0

P01 · FY2002 · AG

AMYLOID AND NEURITIC CHANGES IN EARLY ALZHEIMERS DISEASE$0

P01 · FY2002 · AG

RAB5 AND APP PROCESSING AS RELATED TO AGING$260,149

R01 · FY2001 · AG

PRESENILINS, APOPTOSIS AND AMYLOID BETA PROTEIN$225,603

R01 · FY2001 · AG

NOVEL PRESENILIN BINDING PROTEINS$196,218

P50 · FY2001 · AG

AMYLOID AND NEURITIC CHANGES IN EARLY ALZHEIMERS DISEASE$196,218

P01 · FY2001 · AG

Core--Amyloid Beta$0

P01 · FY2001 · AG

AMYLOID AND NEURITIC CHANGES IN EARLY ALZHEIMERS DISEASE$0

P01 · FY2001 · AG

AMYLOID AND NEURITIC CHANGES IN EARLY ALZHEIMERS DISEASE$0

P01 · FY2001 · AG

RAB5 AND APP PROCESSING AS RELATED TO AGING$252,626

R01 · FY2000 · AG

NOVEL PRESENILIN BINDING PROTEINS$248,655

P50 · FY2000 · AG

PRESENILINS, APOPTOSIS AND AMYLOID BETA PROTEIN$234,867

R01 · FY2000 · AG

AMYLOID AND NEURITIC CHANGES IN EARLY ALZHEIMERS DISEASE$211,980

P01 · FY2000 · AG

AMYLOID AND NEURITIC CHANGES IN EARLY ALZHEIMERS DISEASE$196,218

P01 · FY2000 · AG

Core--Amyloid Beta$0

P01 · FY2000 · AG